Denali Therapeutics Inc (DNLI)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$14.26

Buy

$15.50

arrow-up$0.43 (+2.99%)

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

Prices updated at 12 May 2025, 23:18 EDT

| Prices minimum 15 mins delay

|

Prices in USD

NASDAQ

4.35%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$15.56 - $14.64
	$33.33 - $10.57
	-
	2,087.62m
	-
	-
	1,514,884
	1.92
	1,090,199.82
	1.05
	144.22m
	US24823R1059
	-2.67
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Investment accounts

Adult accounts

Child accounts

Choosing Fidelity

Financial advice & support

Fidelity’s Services

Guides

Guidance and tools

Funds

Choose your funds

Tools and information

Shares

Share dealing

Choose your shares

Tools and information

Pensions & retirement

Pensions, tax & tools

Saving for retirement

Approaching / In retirement